Safety, pharmacokinetics, and immunological activities of multiple intravenous or subcutaneous doses of an anti-HIV monoclonal antibody, VRC01, administered to HIV-uninfected adults: Results of a phase 1 randomized trial

Kenneth H. Mayer, Derrick Goodman, David C. Montefiori et al.|PLoS Medicine|2017

Cited by 132